News - Agila Specialites

Filter

Current filters:

Agila Specialites

Popular Filters

Mylan's deal to acquire Strides Arcolab's unit looks set to proceed

22-08-2013

US generics and specialty drugmaker Mylan (NYSE: MYL) $1.6-billion foreign direct investment proposal…

Agila SpecialitesAsia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesRegulationStrides Arcolab

Mylan stumbles in $1.6 billion bid to take over injectables specialist Agila Specialties in India

09-07-2013

US generics and specialty drugs company Mylan (NYSE: MYL) faces a setback in its plan to acquire Indian…

Agila SpecialitesGenericsMergers & AcquisitionsMylan LaboratoriesStrides Arcolab

GlobalData views potential of Pfizer's rumored acquisition of Strides' Agila unit

20-01-2013

As drug makers continue to jostle for market share and deal with declining revenues from their off-patent…

Agila SpecialitesGenericsMergers & AcquisitionsPfizerPharmaceuticalStrides Arcolab

News briefs: Drug majors eyeing Strides Arcolab unit; Astellas invests in oncology facility

20-08-2012

Leading drug multinationals, including global behemoth Pfizer (NYSE: PFE) and Swiss major Novartis (NOVN:…

Agila SpecialitesAstellas PharmaGenericsHospiraMergers & AcquisitionsNovartisPfizerPharmaceuticalProductionStrides Arcolab

Strides Arcolab unit enters Canada's injectable generics market via JV

16-07-2012

Agila Specialties Pharma Canada, which is part of the injectable drug division of Indian generic drugmaker…

Agila SpecialitesAgila-JampGenericsJamp PharmaMarkets & MarketingMergers & AcquisitionsNorth AmericaStrides Arcolab

Back to top